This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rittner, H. L. Articles by Weyand, C. M. Search for Related Content PubMed PubMed Citation Articles by Rittner, H. L. Articles by Weyand, C. M. Related Collections Genomics Oxidant stress Other Vascular biology

(Circulation Research. 1999;84:1050-1058.)
© 1999 American Heart Association, Inc.

Original Contributions

Tissue-Destructive Macrophages in Giant Cell Arteritis

Heike L. Rittner, Markus Kaiser, Alexander Brack, Luke I. Szweda, Jörg J. Goronzy, Cornelia M. Weyand

From the Department of Medicine (H.L.R., M.K, A.B., J.J.G., C.M.W.), Division of Rheumatology, Mayo Clinic, Rochester, Minn, and the Department of Physiology and Biophysics (L.I.S.), Case Western Reserve University, Cleveland, Ohio.

Abstract—Giant cell arteritis (GCA) is an inflammatory vasculopathy in which T cells and macrophages infiltrate the wall of medium and large arteries. Clinical consequences such as blindness and stroke are related to arterial occlusion. Formation of aortic aneurysms may result from necrosis of smooth muscle cells and fragmentation of elastic membranes. The molecular mechanisms of arterial wall injury in GCA are not understood. To identify mechanisms of arterial damage, gene expression in inflamed and unaffected temporal artery specimens was compared by differential display polymerase chain reaction. Genes differentially expressed in arterial lesions included 3 products encoded by the mitochondrial genome. Immunohistochemistry with antibodies specific for a 65-kDa mitochondrial antigen revealed that increased expression of mitochondrial products was characteristic of multinucleated giant cells and of CD68+ macrophages that cluster in the media and at the media-intima junction. 4-Hydroxy-2-nonenal adducts, products of lipid peroxidation, were detected on smooth muscle cells and on tissue infiltrating cells, in close proximity to multinucleated giant cells and CD68+ macrophages. Also, giant cells and macrophages with overexpression of mitochondrial products were able to synthesize metalloproteinase-2. Our data suggest that in the vascular lesions characteristic for GCA, a subset of macrophages has the potential to support several pathways of arterial injury, including the release of reactive oxygen species and the production of metalloproteinase-2. This macrophage subset is topographically defined and is also identified by overexpression of mitochondrial genes. Because these macrophages have a high potential to promote several mechanisms of arterial wall damage, they should be therapeutically targeted to prevent blood vessel destruction.

Key Words: reactive oxygen species • vasculitis • metalloproteinase • macrophage

This article has been cited by other articles:

				P. Porcu, O. Chavanon, F. Thony, and D. Blin Unusual aortic stent complication after endovascular repair of the descending thoracic aorta in type B dissection in a patient with giant-cell arteritis Interactive CardioVascular and Thoracic Surgery, February 1, 2009; 8(2): 287 - 289. [Abstract] [Full Text] [PDF]

				J. W. Han, K. Shimada, W. Ma-Krupa, T. L. Johnson, R. M. Nerem, J. J. Goronzy, and C. M. Weyand Vessel Wall-Embedded Dendritic Cells Induce T-Cell Autoreactivity and Initiate Vascular Inflammation Circ. Res., March 14, 2008; 102(5): 546 - 553. [Abstract] [Full Text] [PDF]

				M. Segarra, A. Garcia-Martinez, M. Sanchez, J. Hernandez-Rodriguez, E. Lozano, J. M Grau, and M. C Cid Gelatinase expression and proteolytic activity in giant-cell arteritis Ann Rheum Dis, November 1, 2007; 66(11): 1429 - 1435. [Abstract] [Full Text] [PDF]

				Z. Hu, Q. Yang, L. Yang, J. Li, J. Tang, and H. Zhang Cerebral Infarction Due to Giant Cell Arteritis: Three Case Reports Angiology, March 1, 2004; 55(2): 227 - 231. [Abstract] [PDF]

				W. Ma-Krupa, M.-S. Jeon, S. Spoerl, T. F. Tedder, J. J. Goronzy, and C. M. Weyand Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis J. Exp. Med., January 20, 2004; 199(2): 173 - 183. [Abstract] [Full Text] [PDF]

				C. M. Weyand and J. J. Goronzy Giant-Cell Arteritis and Polymyalgia Rheumatica Ann Intern Med, September 16, 2003; 139(6): 505 - 515. [Abstract] [Full Text] [PDF]

				C. M. Weyand and J. J. Goronzy Medium- and Large-Vessel Vasculitis N. Engl. J. Med., July 10, 2003; 349(2): 160 - 169. [Full Text] [PDF]

				W. M. Krupa, M. Dewan, M.-S. Jeon, P. J. Kurtin, B. R. Younge, J. J. Goronzy, and C. M. Weyand Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis Am. J. Pathol., November 1, 2002; 161(5): 1815 - 1823. [Abstract] [Full Text] [PDF]

				A. Borkowski, B. R. Younge, L. Szweda, B. Mock, J. Bjornsson, K. Moeller, J. J. Goronzy, and C. M. Weyand Reactive Nitrogen Intermediates in Giant Cell Arteritis : Selective Nitration of Neocapillaries Am. J. Pathol., July 1, 2002; 161(1): 115 - 123. [Abstract] [Full Text] [PDF]

				A. Sheikhzadeh, I. Tettenborn, F. Noohi, M. Eftekharzadeh, and A. Schnabel Occlusive Thromboaortopathy (Takayasu Disease): Clinical and Angiographic Features and A Brief Review of Literature Angiology, January 1, 2002; 53(1): 29 - 40. [Abstract] [PDF]